Janux Therapeutics, Inc. · NASDAQ:JANX
Adage Capital Management, L.P. reported a 5.31% stake in Janux Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Management, L.P. reported a 5.31% stake in Janux Therapeutics, Inc., 3,061,750 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G).
- Stake
- 5.31%
- Shares
- 3,061,750
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 5.31% | 3,061,750 |
| Robert Atchinson | 5.31% | 3,061,750 |
| Phillip Gross | 5.31% | 3,061,750 |
Source
Related
- Janux Therapeutics, Inc.
- Adage Capital Management, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026